scholarly article | Q13442814 |
P50 | author | Nicole Lichtblau | Q84560342 |
Olivia C Patsalos | Q91149792 | ||
Hubertus Himmerich | Q47421869 | ||
P2093 | author name string | Bethan Dalton | |
Mohammad A A Ibrahim | |||
P2860 | cites work | DNA methylation and inflammation marker profiles associated with a history of depression | Q59543221 |
Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity | Q61772241 | ||
Function, molecular structure and gene expression of IL-4 | Q67929874 | ||
Increased cytokine production in mononuclear cells of healthy elderly people | Q72921117 | ||
Diurnal cortisol rhythm as a predictor of breast cancer survival | Q73911071 | ||
Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects | Q77367415 | ||
[A role for T-helper type 1 and type 2 cytokines in the pathogenesis of various human diseases] | Q77505619 | ||
Protection of mice against the lethal action of an encephalitis virus | Q78882426 | ||
Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies | Q86153175 | ||
[The role of IL-10 in the modulation of the immune response in normal conditions and the tumor environment] | Q88204913 | ||
Different levels of pro- and anti-inflammatory cytokines in patients with unipolar and bipolar depression | Q88738027 | ||
The association of disease activity, pro-inflammatory cytokines, and neurotrophic factors with depression in patients with rheumatoid arthritis | Q88773223 | ||
Comparison of cytokines and prooxidants/antioxidants markers among adults with refractory versus well-controlled epilepsy: A cross-sectional study | Q89211423 | ||
Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized study | Q89238866 | ||
Influence of the inflammatory response on treatment of hepatitis C with triple therapy | Q90279555 | ||
Consequences of persistent depression and apathy in first-episode psychosis - A one-year follow-up study | Q90776999 | ||
Genetics Factors in Major Depression Disease | Q90790025 | ||
Prevention of Major Depression | Q22242001 | ||
Pharmacological treatment for psychotic depression | Q24202347 | ||
Construction of Biologically Functional Bacterial Plasmids In Vitro | Q24562887 | ||
An endotoxin-induced serum factor that causes necrosis of tumors | Q24564406 | ||
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis | Q24597718 | ||
Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity | Q24634258 | ||
The importance of n-6/n-3 fatty acids ratio in the major depressive disorder | Q26738738 | ||
IL-21 Signaling in Immunity | Q26766361 | ||
Perspectives on cytokine-directed therapies in multiple sclerosis | Q26779948 | ||
Induced regulatory T cells: mechanisms of conversion and suppressive potential | Q26823869 | ||
Structural biology of the IL-1 superfamily: key cytokines in the regulation of immune and inflammatory responses | Q26992101 | ||
IL-17 and Th17 Cells | Q27860566 | ||
Virus interference. I. The interferon | Q28181608 | ||
Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment | Q28211825 | ||
Air pollution impairs cognition, provokes depressive-like behaviors and alters hippocampal cytokine expression and morphology. | Q28396234 | ||
Signalling pathways of the TNF superfamily: a double-edged sword | Q29616428 | ||
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways | Q29619779 | ||
Unemployment and ill health: a connection through inflammation? | Q30883761 | ||
Acute phase response in animals: a review | Q33560307 | ||
Major depression and activation of the inflammatory response system | Q33708105 | ||
Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress | Q33708133 | ||
Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array | Q33761815 | ||
Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction | Q33798564 | ||
Cytokine receptor signaling pathways | Q33916985 | ||
Why rejection hurts: a common neural alarm system for physical and social pain | Q33979696 | ||
Inflammatory and Immune Responses to Surgery and Their Clinical Impact | Q38856410 | ||
Cytokines and their relationship to the symptoms and outcome of cancer. | Q34014045 | ||
Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin G | Q34053428 | ||
Cytokines and placental macrophages in regulation of birth activity | Q34055342 | ||
Cytokines in diseases of the endocrine system | Q34056267 | ||
Immunoassay using antigen-enzyme conjugates. | Q34123217 | ||
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment | Q34198749 | ||
Regulation of human intestinal mast cells by stem cell factor and IL-4. | Q34211529 | ||
Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression | Q34242827 | ||
Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity. | Q34247012 | ||
Macrophage cytokines: involvement in immunity and infectious diseases | Q34299710 | ||
Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. | Q34306084 | ||
Anterior cingulate activation and error processing during interferon-alpha treatment | Q34350258 | ||
Depression, cytokines, and pancreatic cancer | Q34453593 | ||
The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacology | Q34608619 | ||
Emil Kraepelin's habilitation and his thesis: a pioneer work for modern systematic reviews, psychoimmunological research and categories of psychiatric diseases. | Q34634706 | ||
Immune system to brain signaling: neuropsychopharmacological implications. | Q34769827 | ||
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis | Q34935593 | ||
C-reactive protein is linked to lower cognitive performance in overweight and obese women | Q35050058 | ||
Antiviral effect of interferon covalently bound to sepharose | Q35110387 | ||
Inflammatory cytokines in general and central obesity and modulating effects of physical activity | Q35187378 | ||
Measurement of cytokines and adhesion molecules in the first 72 hours after severe trauma: association with severity and outcome | Q35226670 | ||
Childhood and later life stressors and increased inflammatory gene expression at older ages | Q35376014 | ||
Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy | Q35659389 | ||
Cytokines in cancer immunity and immunotherapy | Q35951855 | ||
Complex Relationships Between Food, Diet, and the Microbiome. | Q36040980 | ||
Cytokines as a precipitant of depressive illness: animal and human studies | Q36074596 | ||
Tumor necrosis factor and regulation of metabolism in infection: role of systemic versus tissue levels | Q36082587 | ||
Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior | Q36111806 | ||
Stress, depression, and anhedonia: caveats concerning animal models | Q36145083 | ||
Glutamate-mediated glial injury: mechanisms and clinical importance | Q36277315 | ||
T-helper cell type-2 regulation in allergic disease | Q36327479 | ||
Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial | Q36403127 | ||
Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression | Q36637116 | ||
Social stress induces neurovascular pathology promoting depression | Q47282467 | ||
Cytokine alterations in panic disorder: A systematic review | Q47293699 | ||
A Systematic Review of Tumor Necrosis Factor-α in Post-Traumatic Stress Disorder: Evidence from Human and Animal Studies | Q47380785 | ||
T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome | Q47587653 | ||
Postpartum depression and vitamin D: A systematic review | Q47638701 | ||
A Systematic Review of Interleukin-1β in Post-Traumatic Stress Disorder: Evidence from Human and Animal Studies. | Q47735513 | ||
Contributions of early adversity to pro-inflammatory phenotype in infancy: the buffer provided by attachment security | Q47801192 | ||
Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection. | Q47830428 | ||
Role of Neuroinflammation in Evolution of Childhood Epilepsy | Q47913847 | ||
Age and neuroinflammation: a lifetime of psychoneuroimmune consequences | Q47954383 | ||
Neuroinflammation - A major cause for striatal dopaminergic degeneration in Parkinson's disease. | Q48027557 | ||
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression | Q48063321 | ||
Effect of Mirtazapine Treatment on Serum Levels of Brain-Derived Neurotrophic Factor and Tumor Necrosis Factor-α in Patients of Major Depressive Disorder with Severe Depression | Q48064508 | ||
Enhanced inflammatory and T-helper-1 type responses but suppressed lymphocyte proliferation in patients with seasonal affective disorder and treated by light therapy | Q48078669 | ||
Astrocyte-microglia cooperation in the expression of a pro-inflammatory phenotype | Q48088702 | ||
TNF-α and IL-6 serum levels: neurobiological markers of alcohol consumption in alcohol-dependent patients? | Q48202956 | ||
The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression - report of two cases. | Q48219182 | ||
The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery | Q48291064 | ||
Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity | Q48292772 | ||
Diurnal cortisol decline is related to coronary calcification: CARDIA study | Q48408038 | ||
Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy | Q48490128 | ||
Antidepressant effects of TNF-α blockade in an animal model of depression | Q48521076 | ||
Opiate receptor mediated effects of IFN-alpha and lymphocyte derived endorphin-like peptides | Q48576753 | ||
Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factoralpha signaling during peripheral organ inflammation. | Q48736659 | ||
Protection of rat primary hippocampal cultures from A beta cytotoxicity by pro-inflammatory molecules is mediated by astrocytes. | Q48924051 | ||
Prefrontal cortical hypometabolism during low-dose interferon alpha treatment | Q49114631 | ||
Neurobiological links between depression and AD: The role of TGF-β1 signaling as a new pharmacological target. | Q50039451 | ||
Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. | Q50335911 | ||
Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C. | Q50571918 | ||
Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction. | Q51032231 | ||
Impact of antipsychotics on cytokine production in-vitro. | Q51461858 | ||
Peripheral Blood Grafts for T-Cell Replete Haploidentical Transplantation Increase the Incidence and Severity of Cytokine Release Syndrome. | Q52717752 | ||
[Analysis of the association of interleukin 4 and interleukin 10 gene variants with basic personality traits]. | Q53726765 | ||
Association between pro- and anti-inflammatory cytokines and depressive symptoms in patients with diabetes-potential differences by diabetes type and depression scores. | Q54224164 | ||
The role of IL-22 in the resolution of sterile and nonsterile inflammation. | Q54224246 | ||
Astrocytes are GABAergic cells that modulate microglial activity. | Q54403433 | ||
Gut microbiota-dependent modulation of innate immunity and lymph node remodeling affects cardiac allograft outcomes | Q57029351 | ||
A meta-analysis of cytokine concentrations in eating disorders | Q57172886 | ||
Regulatory T cells increased while IL-1β decreased during antidepressant therapy | Q57243415 | ||
Depression, comorbidities and the TNF-α system | Q57243497 | ||
Prädiktive Faktoren der Depression und ihrer Therapie | Q58443199 | ||
Assay of Plasma Insulin in Human Subjects by Immunological Methods | Q59055483 | ||
The causes and consequences of variation in human cytokine production in health | Q59358541 | ||
Impact of Serum Cytokine Levels on EEG-Measured Arousal Regulation in Patients with Major Depressive Disorder and Healthy Controls | Q38915949 | ||
The Microbiome-Gut-Brain Axis in Health and Disease | Q39121931 | ||
IL-17 and IL-22 in immunity: Driving protection and pathology | Q39179415 | ||
The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases | Q39186373 | ||
Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample | Q39187085 | ||
Innate lymphoid cell-derived cytokines in autoimmune diseases | Q39289055 | ||
The potential role of neuroinflammation and transcription factors in Parkinson disease | Q39342497 | ||
Interleukin-1 Receptor Activation by Systemic Lipopolysaccharide Induces Behavioral Despair Linked to MAPK Regulation of CNS Serotonin Transporters | Q39839633 | ||
Commentary. Similarities of T cell function in cell-mediated immunity and antibody production | Q39875547 | ||
Pro-inflammatory cytokines and psychotherapy in depression: Results from a randomized clinical trial | Q40069978 | ||
Urban air pollution, poverty, violence and health--Neurological and immunological aspects as mediating factors | Q40282926 | ||
The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters | Q40321786 | ||
Obesity-induced inflammatory changes in adipose tissue. | Q40348859 | ||
Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever | Q40407932 | ||
Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans | Q40428160 | ||
Tumor necrosis factor: a pleiotropic cytokine and therapeutic target | Q40759728 | ||
Functions of T-cell subsets and cytokines in mycobacterial infections. | Q40963320 | ||
Immune-neuro-endocrine interactions: facts and hypotheses | Q40993419 | ||
Cocaine abuse and effects in the serum levels of cytokines IL-6 and IL-10. | Q41041110 | ||
IL2- and IL4-dependent proliferation of T-cell clones derived early after allogeneic bone marrow transplantation: studies of patients with chronic myelogenous leukaemia | Q41120755 | ||
Cytokine effects on CNS biogenic amines | Q41138890 | ||
Preanalytical factors and the measurement of cytokines in human subjects | Q41151006 | ||
Pathway analysis of genome-wide association datasets of personality traits | Q41159670 | ||
Interferon-alpha and its effects on the cytokine cascade: a pro- and anti-inflammatory cytokine | Q41342078 | ||
The innate defense antimicrobial peptides hBD3 and RNase7 are induced in human umbilical vein endothelial cells by classical inflammatory cytokines but not Th17 cytokines | Q41511936 | ||
Interleukin 4 (IL) 4 up-regulates gene and surface IL 1 receptor type I in murine T helper type 2 cells | Q41646984 | ||
Cortisol, cytokines, and hippocampal volume interactions in the elderly | Q41880180 | ||
Increased cytokine production by peripheral blood mononuclear cells from healthy elderly people | Q41951933 | ||
IL-4-producing B cells regulate T helper cell dichotomy in type 1- and type 2-controlled diseases. | Q41997519 | ||
Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy | Q42508936 | ||
TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. | Q42972510 | ||
Altered expression of CD4(+)CD25(+) regulatory T cells and its 5-HT(1a) receptor in patients with major depression disorder. | Q43245464 | ||
Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin | Q43537575 | ||
Paroxetine for the prevention of depression induced by high-dose interferon alfa | Q43556890 | ||
Obesity and depression: an overview on the complex interactions of two diseases | Q43594226 | ||
Cytokine-associated emotional and cognitive disturbances in humans | Q43601371 | ||
Stress-induced cytokine changes in rats. | Q43802793 | ||
Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system | Q43859445 | ||
Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine | Q44272329 | ||
Biological manifestations of the tumor necrosis factor effect and its role in the pathogenesis of various diseases | Q44280996 | ||
Human leukocyte interferon (HuIFN-alpha): potent endorphin-like opioid activity | Q44352623 | ||
Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome. | Q44507194 | ||
Anti- and pro-inflammatory considerations in antidepressant use during medical illness: bupropion lowers and mirtazapine increases circulating tumor necrosis factor-alpha levels | Q44714325 | ||
Immune and neuroendocrine correlates of temperament in infancy. | Q45073584 | ||
The metabolic syndrome, inflammation, and risk of cognitive decline | Q45145786 | ||
Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium. | Q45163801 | ||
Suicidal patients are deficient in vitamin D, associated with a pro-inflammatory status in the blood. | Q45170896 | ||
p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process | Q45280522 | ||
The association between bereavement and biomarkers of inflammation. | Q45696703 | ||
The production of interferon in brains of mice infected with an arthropod-borne virus | Q45718275 | ||
Impact of mood stabilizers and antiepileptic drugs on cytokine production in-vitro | Q45791553 | ||
Peripheral proinflammatory cytokines in Chinese patients with generalised anxiety disorder. | Q46188910 | ||
Mood stabilizers--past, present and future | Q46390195 | ||
Cytokine-induced enhancement of calcium-dependent glutamate release from astrocytes mediated by nitric oxide | Q46768070 | ||
Maternal Systemic Interleukin-6 During Pregnancy Is Associated With Newborn Amygdala Phenotypes and Subsequent Behavior at 2 Years of Age. | Q46974603 | ||
Systematic review of proinflammatory cytokines in obsessive-compulsive disorder | Q36764603 | ||
Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration | Q36806349 | ||
IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. | Q36813334 | ||
Depressive symptoms and metabolic syndrome: is inflammation the underlying link? | Q37052593 | ||
Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1. | Q37111098 | ||
Synergistic relationships among stress, depression, and troubled relationships: insights from psychoneuroimmunology | Q37276319 | ||
Impact of antidepressants on cytokine production of depressed patients in vitro | Q37357893 | ||
Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals | Q37370987 | ||
Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. | Q37459522 | ||
Anti-inflammatory drugs in psychiatry | Q37597291 | ||
Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions | Q37601429 | ||
Polyunsaturated fatty acids, neuroinflammation and well being. | Q37708844 | ||
Stromal cell biology--a way to understand the evolution of cardiovascular diseases | Q37727745 | ||
Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions | Q37800377 | ||
Fibroblast activation in vascular inflammation | Q37831401 | ||
The influence of cytokines on wakefulness regulation: clinical relevance, mechanisms and methodological problems. | Q38019369 | ||
Inflammatory cytokines in experimental and human stroke. | Q38022155 | ||
The role of cytokines in cardiovascular disease in menopause | Q38044746 | ||
Cytokine assays: an assessment of the preparation and treatment of blood and tissue samples | Q38100529 | ||
Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis | Q38114586 | ||
Research review: the role of cytokines in depression in adolescents: a systematic review | Q38136672 | ||
Cytokines as biomarkers in depressive disorder: current standing and prospects. | Q38154918 | ||
Recombinant human interferons | Q38159781 | ||
Smoking and inflammation: evidence for a synergistic role in chronic disease | Q38169801 | ||
Targeting classical IL-6 signalling or IL-6 trans-signalling in depression? | Q38189135 | ||
Stimulation of systemic low-grade inflammation by psychosocial stress. | Q38194388 | ||
Refractory asthma - beyond step 5, the role of new and emerging adjuvant therapies. | Q38285983 | ||
Weight Gain and Metabolic Changes During Treatment with Antipsychotics and Antidepressants. | Q38534809 | ||
Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment? | Q38565570 | ||
Management of depression after myocardial infarction | Q38567458 | ||
Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression | Q38627027 | ||
The role of IL-6 in host defence against infections: immunobiology and clinical implications | Q38725223 | ||
Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis. | Q38726626 | ||
Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies | Q38765932 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | interleukins | Q194908 |
cytokine | Q212354 | ||
research question | Q1438033 | ||
tumor necrosis factor | Q21173843 | ||
P304 | page(s) | 30 | |
P577 | publication date | 2019-02-07 | |
P1433 | published in | Frontiers in Psychiatry | Q27723495 |
P1476 | title | Cytokine Research in Depression: Principles, Challenges, and Open Questions | |
P478 | volume | 10 |
Q91867622 | Depressive Symptom Clusters in Relation to Body Weight Status: Results From Two Large European Multicenter Studies |
Q91647621 | Inflammation as the Potential Basis in Depression |
Q97517432 | Is There an Association or Not?-Investigating the Association of Depressiveness, Physical Activity, Body Composition and Sleep With Mediators of Inflammation |
Q97885906 | Long-Term Exposure to Ceftriaxone Sodium Induces Alteration of Gut Microbiota Accompanied by Abnormal Behaviors in Mice |
Q90240601 | Personalized Psychiatry and Depression: The Role of Sociodemographic and Clinical Variables |
Q89948172 | Porcine liver decomposition product-derived lysophospholipids promote microglial activation in vitro |
Q99364842 | Single-cell mass cytometry of microglia in major depressive disorder reveals a non-inflammatory phenotype with increased homeostatic marker expression |
Q92032433 | The neuroprotective effect of Riparin IV on oxidative stress and neuroinflammation related to chronic stress-induced cognitive impairment |
Search more.